Lddd.Pk
LDDD.PK operates in the healthcare facilities and services industry, focusing on biotechnology, and generates revenue primarily through its services and equipment offerings.
Business. LDDD.PK operates in the healthcare facilities and services industry, focusing on biotechnology, and generates revenue primarily through its services and equipment offerings.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsFY 2026 earnings (expected)2026-08-09 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
LDDD.PK operates in the healthcare facilities and services industry, focusing on biotechnology, and generates revenue primarily through its services and equipment offerings.
LDDD.PK maintains a strong liquidity position, with a current ratio of 2.18, indicating the company can easily cover its short-term liabilities with its current assets. The company has no long-term debt and holds significant cash and equivalents of $1.64 million, which supports its liquidity and financial flexibility. The free cash flow of $570,170 further reinforces its ability to fund operations and potentially invest in growth opportunities.
In terms of profitability, LDDD.PK demonstrates a return on equity (ROE) of 38.87% and a return on assets (ROA) of 21.65%, both of which are strong indicators of efficient capital use and asset management. These metrics suggest the company is generating substantial returns relative to its equity and total assets, outperforming many industry peers in terms of profitability.
The company's revenue is concentrated in a single business segment, as disclosed in its financials, with no geographic diversification provided in the available data. This lack of segment and geographic diversification could expose the company to higher operational and market risks if its primary business line or region experiences a downturn.
Looking ahead, LDDD.PK is positioned for continued growth, with a strong operating cash flow of $277,370 and a net income of $460,440. While specific growth projections for the next fiscal year are not provided, the company's financial health and profitability suggest a positive trajectory. The absence of dilution risk and the low liquidity risk further support a stable growth outlook.
The risk assessment for LDDD.PK indicates a low level of liquidity and dilution risk, with no immediate filing-based flags detected. The company's capital structure is robust, with no long-term debt and a high proportion of equity, reducing the likelihood of financial distress. The absence of dilution risk is also a positive factor, as it suggests the company is not likely to issue additional shares in the near term, preserving shareholder value.
Recent filings and transcripts do not indicate any material events or strategic shifts that would significantly impact the company's operations or financial performance. The company appears to be maintaining a stable and profitable business model without major disruptions.
- LDDD.PK has a strong liquidity position with a current ratio of 2.18 and no long-term debt.
- The company generates high returns on equity (38.87%) and assets (21.65%), indicating efficient capital use.
- Revenue is concentrated in a single business segment, which may increase operational risk.
- The company is positioned for continued growth with strong operating cash flow and net income.
- Low liquidity and dilution risk support a stable financial outlook.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- LDDD.PK Market data — financials · 2026-05-28
Ownership & reference
Insider activity
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Current ratio (FY 2025-12-31): 1.57xDerived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -19.3%Derived (calculated)
- Debt-to-equity (FY 2025-12-31): 1.30xDerived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 15.5%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): -4.4%Derived (calculated)
- Shares outstanding (annual): 30.02MSEC XBRL filing
- Total liabilities (annual): USD 1.14MSEC XBRL filing
- Current assets (annual): USD 1.76MSEC XBRL filing
- Shareholders' equity (annual): USD 880.36KSEC XBRL filing
- Current liabilities (annual): USD 1.12MSEC XBRL filing
- Total assets (annual): USD 2.1MSEC XBRL filing
- Gross profit (YoY) (2025-06-30 vs 2024-06-30): -42.2%Derived (calculated)
- Operating income (YoY) (2025-06-30 vs 2024-06-30): -72.7%Derived (calculated)
- Net income (YoY) (2025-06-30 vs 2024-06-30): -63.3%Derived (calculated)
- Operating cash flow (YoY) (2025-06-30 vs 2024-06-30): -52.4%Derived (calculated)
- Net margin (FY 2025-06-30): 10.8%Derived (calculated)
- Gross margin (FY 2025-06-30): 97.9%Derived (calculated)
- Capex (YoY) (2025-06-30 vs 2024-06-30): -80.6%Derived (calculated)
- Cost of revenue (YoY) (2025-06-30 vs 2024-06-30): -47.4%Derived (calculated)
- EPS (basic) (YoY) (2025-06-30 vs 2024-06-30): -64.3%Derived (calculated)
- Revenue (YoY) (2025-06-30 vs 2024-06-30): -42.3%Derived (calculated)
- EPS (diluted) (YoY) (2025-06-30 vs 2024-06-30): -64.3%Derived (calculated)
- Operating income (annual): USD 552.68KSEC XBRL filing
- EPS (diluted) (annual): USD-PER-SHARES 0SEC XBRL filing